NKF 2011 Anemia

Switch From Darbepoetin to Epoetin May Be Beneficial

LAS VEGAS—Switching anemic pre-dialysis chronic kidney disease (CKD) from darbepoetin to epoetin is associated with longer dosing intervals and lower drug costs, and hemoglobin levels are maintained in the recommended target range, according to a study presented at the National Kidney Foundation’s Spring Clinical Meetings.

Next post in NKF 2011 Anemia